Skip to main content



commentary Commentary

Commentary: Pharmacists can do more on frontlines of COVID-19 fight

US pharmacists can now test for coronavirus. They are qualified to help with community care, home care and more if allowed to, says a healthcare expert.

Commentary: Pharmacists can do more on frontlines of COVID-19 fight

A pharmacist wearing a protective respiratory mask tends to a customer in Codogno, southeast of Milan, on Feb 22, 2020. (Photo: Miguel MEDINA / AFP)

LOS ANGELES, California: Italy’s death toll from the novel coronavirus climbed to one of the highest in the world, its doctors made a plea to other countries: Manage the pandemic in the community, not in hospitals and emergency rooms.

When people with COVID-19 show up at hospitals, they can spread the virus to other patients and healthcare workers. Italian authorities believe that the instinct to go to the emergency room first, even when the symptoms aren’t severe, contributed to the country’s current disaster.

Like Italy’s, the United States’ health system is hospital-centered. As a result, pandemics can quickly overwhelm the hospital system, limiting its capacity to deal with other urgent medical conditions.

READ: Commentary: Why is Germany’s COVID-19 fatality rate so low?

READ: Commentary: COVID-19 collapse exceeds any recession in the last 150 years

But an alternative exists that could help manage the pandemic among the majority of COVID-19 patients with mild or moderate symptoms.

It is the 67,000 community pharmacies in the US, whose numbers dwarf the 5,500 hospitals and 1,400 community health centres. They are staffed by 175,000 pharmacists frequently referred to as the most overtrained and underutilised health care professionals in America.


Many pharmacies already offered testing for streptococcal and influenza infections, but it wasn’t until Apr 8 that US pharmacies were authorized to order and administer COVID-19 tests.

Pharmacists are now positioned to broadly perform testing that will provide vital data as public health professionals strategise how best to slow the virus’s spread.

A pharmacist selects drugs inside her pharmacy. (Photo: REUTERS/Regis Duvignau)

Testing is an established tactic for significantly reducing the size of an infectious disease outbreak. 

Widespread testing for the coronavirus in countries including China, South Korea, Singapore and Germany and the subsequent isolation of infected patients appear to be common factors in containing the spread and limiting deaths from the disease.

But offering testing is just one step.  


In a number of programmes across the county, pharmacists have shown that they can dramatically improve control of medical conditions, avoid the need for hospital admissions and reduce health care costs.

When pharmacists in Los Angeles teamed up with barbershops to manage high blood pressure for black patients, nearly 90 per cent of the patients reached their blood pressure target, compared to only one-third of patients who received traditional medical care.

A pharmacist wears a mask as she speaks to a customer outside a pharmacy in Milan, Italy. (Photo: Claudio Furlan/LaPresse via AP)

In Kern County, California, another programme had pharmacists contact 1,100 vulnerable patients shortly after they were released from hospitals to ensure they were taking their medications correctly.

The patients’ hospital readmissions rate dropped by 32 per cent, saving an average of US$2,139 per patient.

A University of Southern California study demonstrated that patients whose diabetes medications were managed by a pharmacist were three times more likely to reach their blood sugar targets.

READ: Commentary: COVID-19 may be a mild illness for most people

READ: Commentary: Boris Johnson’s COVID-19 illness has made him more powerful


In the case of COVID-19, pharmacists could be a first point of contact for people who suspect they have been infected but aren’t seriously ill.

With the proper precautions, pharmacists can offer drive-up testing and evaluation services that allow patients to remain in their cars, and they can provide selective home visits for those who are quarantined or self-isolated.

Pharmacists can also refer patients for further medical care when needed.

A woman waits behind a sheet of protective plastic at the pharmacist's counter at a CVS Pharmacy in Manhattan during the outbreak of the coronavirus disease (COVID-19) in New York City, New York on, Mar 27, 2020. (Photo: REUTERS/Mike Segar)

Why wasn’t all this already happening on a wide scale? Why did it require the Public Readiness and Emergency Preparedness Act, brought on by the current pandemic?

The reason is pharmacists are not recognised by the US government as healthcare providers. They do not have access to critical national insurance reimbursement codes for providing medical services beyond filling prescriptions.

This means they cannot be paid by the government or insurance companies for patient care services they have the training to provide. Without the recent authorisation from the US Department of Health and Human Services, pharmacists would not have been able to perform COVID-19 testing.

READ: Commentary: Trump fights a two-front war on the coronavirus

READ: Commentary: In Singapore, laws are necessary for trickle-down policies to work

Pharmacists are trained to ensure that over 10,000 prescription drugs are used properly. Advanced services, such as comprehensive medication management, provide an individualised evaluation, and pharmacists can adjust medications in partnership with physicians and follow up with patients until treatment goals are reached.

With strong links between common diseases, such as high blood pressure, diabetes and asthma, and complications from COVID-19, these services are more important than ever.

COVID-19 has created new and unprecedented challenges for our health care system. With more than 90 per cent of the US population within mere kilometres of a pharmacy, pharmacists are well-situated to step in to help beat this national crisis.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak:

Steven W Chen is Associate Dean for Clinical Affairs, University of Southern California. This commentary first appeared in The Conversation.

Source: CNA/sl


Also worth reading